Cannabis-Based Treatment Guide
Cannabis has been used in oncology for decades, with FDA-approved synthetic cannabinoids (dronabinol, nabilone) for chemotherapy-induced nausea since the 1980s. This guide covers evidence-based applications for symptom management during cancer treatment — including nausea, pain, appetite loss, anxiety, and sleep — while addressing critical safety considerations for oncology patients.
Critical Warning: Always inform your oncologist before using cannabis during cancer treatment. CBD inhibits enzymes that metabolize many chemotherapy drugs, potentially causing dangerous drug interactions. Cannabis does NOT treat cancer itself.
Chemotherapy-Induced Nausea & Vomiting (CINV)
Strongest evidence. THC activates CB1 receptors in the dorsal vagal complex and nucleus tractus solitarius, suppressing the vomiting reflex. FDA-approved dronabinol and nabilone used since 1985.
Cancer Pain
THC and CBD provide analgesia via CB1/CB2 receptors and opioid system potentiation. Particularly effective for neuropathic pain from chemotherapy (CIPN) and bone pain from metastases.
Appetite Stimulation & Cachexia
THC stimulates appetite via hypothalamic CB1 receptors, increasing ghrelin and reducing leptin. Addresses cancer cachexia syndrome — a major cause of treatment discontinuation and mortality.
Anxiety & Depression
CBD reduces cancer-related anxiety and existential distress. Particularly valuable in palliative care settings where quality of life is the primary treatment goal.
Sleep Disruption
THC reduces sleep latency and improves sleep quality disrupted by pain, anxiety, and treatment side effects. CBN-rich products particularly effective for sleep maintenance.
Preclinical (cell and animal) studies show cannabinoids can kill cancer cells in laboratory settings. However: